L
Lionco Pharmaceutical Group Co Ltd
SSE:603669
Lionco Pharmaceutical Group Co Ltd
SSE:603669
Price:
4.62
CNY
-0.22%
Market Closed
Market Cap:
¥3.3B
Relative Value
The Relative Value of one Lionco Pharmaceutical Group Co Ltd stock under the Base Case scenario is hidden CNY. Compared to the current market price of 4.62 CNY, Lionco Pharmaceutical Group Co Ltd is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Lionco Pharmaceutical Group Co Ltd Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Lionco Pharmaceutical Group Co Ltd Competitors
Lionco Pharmaceutical Group Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CN |
L
|
Lionco Pharmaceutical Group Co Ltd
SSE:603669
|
3.3B CNY | 7.7 | -28.1 | -42.7 | -42.7 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
964.4B USD | 14.8 | 46.7 | 31.5 | 33.5 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
572.6B USD | 6.1 | 21.4 | 14.9 | 18.2 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
284.3B CHF | 4.6 | 30.2 | 12.8 | 14.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
297.7B USD | 4.6 | 16.3 | 10.2 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
228.8B CHF | 5.2 | 21 | 13 | 16.7 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
217.7B GBP | 5.2 | 32 | 15.3 | 22.4 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.3T DKK | 4.2 | 12.7 | 9.3 | 10.9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
151.1B USD | 2.4 | 19.4 | 7.3 | 9.7 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
120.9B USD | 2.5 | 20 | 7.1 | 9.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
